NCT03416114 RegistRare: a Retro-prospective Registry of Rare Primary Headaches in Italian Tertiary Headache Centres
| NCT ID | NCT03416114 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Silvia Benemei |
| Condition | Headache Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2017-09-01 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2017-09-01 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Retro-prospective survey on specific and overall prevalence and incidence of rare primary headaches (Part One, Chapter 3 and Chapter 4, ICHD-3 beta) in patients referred to Italian Tertiary Headache Centres in a 3-year (May 1, 2014-April 30, 2017 - retrospective data) and annually (from May 1, 2017 - prospective data).
Eligibility Criteria
Inclusion Criteria: * diagnosis of rare primary headaches (Part One, Chapter 3 and Chapter 4, ICHD-3 beta) * signed informed consent Exclusion Criteria: * none
Contact & Investigator
Silvia Benemei, MD
STUDY CHAIR
Careggi University Hospital
Frequently Asked Questions
Who can join the NCT03416114 clinical trial?
This trial is open to participants of all sexes, studying Headache Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03416114 currently recruiting?
Yes, NCT03416114 is actively recruiting participants. Contact the research team at silvia.benemei@unifi.it for enrollment information.
Where is the NCT03416114 trial being conducted?
This trial is being conducted at Florence, Italy.
Who is sponsoring the NCT03416114 clinical trial?
NCT03416114 is sponsored by Silvia Benemei. The principal investigator is Silvia Benemei, MD at Careggi University Hospital. The trial plans to enroll 3,000 participants.